Squarepoint’s Kinnate Biopharma Inc. Common Stock KNTE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-23,187
| Closed | -$61.7K | – | 3131 |
|
|
2024
Q1 | $61.7K | Sell |
23,187
-35,650
| -61% | -$94.8K | ﹤0.01% | 2308 |
|
|
2023
Q4 | $139K | Sell |
58,837
-17,212
| -23% | -$40.8K | ﹤0.01% | 2221 |
|
|
2023
Q3 | $106K | Sell |
76,049
-72,166
| -49% | -$101K | ﹤0.01% | 2246 |
|
|
2023
Q2 | $449K | Buy |
+148,215
| New | +$449K | ﹤0.01% | 1645 |
|
|
2023
Q1 | – | Sell |
-25,091
| Closed | -$153K | – | 2912 |
|
|
2022
Q4 | $153K | Buy |
+25,091
| New | +$153K | ﹤0.01% | 1963 |
|
|
2022
Q2 | – | Sell |
-14,064
| Closed | -$158K | – | 2774 |
|
|
2022
Q1 | $158K | Buy |
+14,064
| New | +$158K | ﹤0.01% | 1960 |
|
|
2021
Q3 | – | Sell |
-13,272
| Closed | -$309K | – | 2881 |
|
|
2021
Q2 | $309K | Buy |
+13,272
| New | +$309K | ﹤0.01% | 1944 |
|